Jeena Sikho Lifecare will host a physical group meeting with investors and analysts on September 3, 2026. The session is part of the Twelfth Edition of the Ashwamedh-Elara India Dialogue.

The event will take place at the Grand Hyatt in Santacruz, Mumbai, from 10:00 am to 5:00 pm. Management will discuss publicly available documents during the interaction. The company stated that no unpublished price-sensitive information will be shared.

Meeting Details

The schedule is indicative and subject to change based on unforeseen developments by the company or organizer. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Manish Grover, Managing Director, signed the intimation letter dated August 29, 2026. The notice was issued from the company's registered office in Zirakpur, Punjab.

Jeena Sikho Lifecare Ltd announced the launch of nine new products on August 26, 2026, expanding its Ayurvedic and wellness portfolio. The company disclosed the move pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The new offerings target the domestic market and include a mix of topical patches and liquid formulations. Eight of the nine products are Arishta (fermented herbal preparations) in 500 ml volumes, while one is a headache relief patch.

Product Portfolio Expansion

The launch introduces specific therapeutic categories ranging from pain management to organ-specific care. All products are scheduled for release on August 26, 2026.

Regulatory Disclosure

The company filed the intimation with the National Stock Exchange of India Limited and BSE Limited. The disclosure references SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Manish Grover, Managing Director, signed the filing from Zirakpur, Punjab.